Relypsa Inc.

(RLYP) Trade

By |

Profile

Relypsa Inc is a biopharmaceutical company engaged in the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.

Contact Information

Website: www.relypsa.com
Main Phone: +1 650 421-9500
Address: 100 Cardinal Way
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: NGS
CEO: John A. Orwin
Employees: 429
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 32.12 52 Wk Low 10.26
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,882,597.00 EPS (TTM) -5.77 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Kristine M. Ball 1,000
Thomas J. Schuetz 1,000
John A. Orwin 1,000
Scott M. Rocklage 1,000
Scott M. Rocklage 1,000
Jonathan T. Silverstein 1,000
Ronald Hunt 1,000
Last 10 Sell Shares
Kenneth J. Hillan 1,000
Daniel K. Spiegelman 1,000
Helen Torley 1,000
David W.J. McGirr 1,000
John P. Butler 1,000
Paul J. Hastings 1,000
Wilhelm Stahl 1,000
Lance Berman 1,000
John A. Orwin 1,000
John A. Orwin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 32 32 32 32
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 28.67 28.67 28.67 28.67
Standard Deviation 5.32 5.32 5.32 5.32
Date of Most Recent Estimate 09/01/16 09/01/16 09/01/16 09/01/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 3 8 8
Moderate Buy 0 0 0 0
Hold 7 7 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 0
Mean Rec. 2.75 2.4 1.66 1.55